Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	263.23	179.36	129.79	191.25
Cash & Short-Term Investments	263.23	179.36	129.79	191.25
Cash Growth	70.35%	38.19%	-32.14%	-
Accounts Receivable	236.36	276.66	219.28	159.51
Other Receivables	2.09	1.94	0.16	0.48
Receivables	238.45	278.6	219.44	159.98
Inventory	18.83	38.57	18.81	32.6
Prepaid Expenses	192.7	230.46	181.38	131.04
Other Current Assets	2.04	2.28	2.18	0.75
Total Current Assets	715.24	729.26	551.6	515.62
Property, Plant & Equipment	9.31	10.91	15.28	9.34
Other Intangible Assets	1.12	1.42	2.08	2.76
Long-Term Deferred Tax Assets	1.74	1.78	1.59	2.62
Other Long-Term Assets	134.86	193.87	137.82	110.42
Total Assets	864.51	937.24	708.36	640.76
Accounts Payable	138	216.09	191.39	127.08
Short-Term Debt	70	100	-	40
Current Portion of Leases	1.55	2.05	2.74	5.9
Current Income Taxes Payable	14.02	13.08	10.22	11.91
Current Unearned Revenue	7.81	12.64	11.97	14.98
Other Current Liabilities	136	44.69	39.13	38.07
Total Current Liabilities	367.38	388.54	255.45	237.94
Long-Term Leases	2.68	3.43	5.47	1.01
Long-Term Unearned Revenue	-	-	-	1.17
Long-Term Deferred Tax Liabilities	0.55	0.59	0.54	1.02
Other Long-Term Liabilities	3.56	3.88	3.67	0.56
Total Liabilities	374.16	396.44	265.13	241.69
Common Stock	236.26	236.26	201.6	168
Additional Paid-In Capital	142.19	150.72	132.9	132.9
Retained Earnings	80.1	114.57	79.92	69.64
Comprehensive Income & Other	-1.23	4.43	1.33	1.46
Total Common Equity	457.31	505.98	415.76	372.01
Minority Interest	33.03	34.83	27.47	27.06
Shareholders' Equity	490.35	540.8	443.23	399.07
Total Liabilities & Equity	864.51	937.24	708.36	640.76
Total Debt	74.23	105.47	8.21	46.91
Net Cash (Debt)	189	73.89	121.58	144.35
Net Cash Growth	342.87%	-39.23%	-15.78%	-
Net Cash Per Share	8.00	3.14	5.23	6.43
Filing Date Shares Outstanding	23.63	23.63	23.18	22.38
Total Common Shares Outstanding	23.63	23.63	23.18	22.38
Working Capital	347.87	340.72	296.15	277.68
Book Value Per Share	19.36	21.42	17.93	16.62
Tangible Book Value	456.2	504.55	413.68	369.24
Tangible Book Value Per Share	19.31	21.36	17.84	16.50
Machinery	-	16.63	15.93	16.01
Leasehold Improvements	-	6.67	6.59	2.97

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.